Hints and tips:
Related Special Reports
...Lewis said he did not have “any formal involvement” with Morrisons or MFG....
...It has been expanding its Chinese business, with recent approvals of drugs for cancer and one for a rare disease....
Stocks in Tokyo on track to surpass all-time record reached in December 1989
...leo.lewis@ft.com...
More US-China decoupling in focus for investors as Tokyo market closes in on all-time high
...Marc FilippinoLeo Lewis is the FT’s Asia business editor. [MUSIC PLAYING] Marc FilippinoIn other market news, Reddit is gonna float....
...Japan’s trio of convenience store groups have fought each other on multiple fronts, with each increasing and improving their offerings of coffee, fast food, pre-prepared meals, drugs and exclusive goods....
...Nikkei Inc, which calculates and publishes the index, owns the Financial Times....
...Leo Lewis Yeah....
...Fellow proxy adviser Glass Lewis also highlighted Botín’s pay rise as a concern in its report seen by the FT, but backed the overall package because of the bank’s strong results....
Lenders in US, Asia and Europe hit by exposure to sector struggling with lower occupancy and higher interest rates
...But if the M&A deals of the 1980s were a demonstration of Japan Inc’s ambitions to take on the world, corporate executives say today’s overseas rush is driven by the need to find new revenue outside their...
Departure from Tokyo exchange after 74 years follows shareholder revolt and leveraged buyout
...ISS’s recommendations diverge from fellow proxy adviser Glass Lewis, which earlier this week backed all of Disney’s board nominees....
...It acquired obesity drug developer Carmot Therapeutics for $2.7bn....
The country’s regulator is exerting ‘unprecedented’ influence to unlock value
...As our colleagues Leo Lewis and Kana Inagaki reported yesterday: Japanese finance officials have privately told analysts that they do not believe the yen’s recent weakening is justified by the BoJ’s historic...
...The drug is not yet approved in the US or Europe....
Global investment banks have struggled to make a profit in the country
...know: business Novo Nordisk announced a €1bn deal for a German biotech developing therapies to treat heart disease, as the Danish group seeks to branch out from its blockbuster diabetes and weight loss drugs...
...Drugs of the GLP-1 group suppress appetite with remarkable effectiveness. Weight loss success stories have resonated in Wall Street and the C-suite....
...— Fair coins tend to land on the same side they started: evidence from 350,757 flips (Cornell University) — The EU’s endless drug shortage, its fragile supply chains and the bizarre crab connection (ING...
...AbbVie’s Humira, used for a range of autoimmune diseases, became the world’s best-selling drug but has recently had its market exclusivity expire....
Opposition from rival SK Hynix puts brakes on Bain Capital’s ambitions to create US-Japan chip giant
Plan to list groups that are meeting guidelines will enhance investor scrutiny of laggards
International Edition